PEAC: An Ultrasensitive and Cost-Effective MRD Detection System in Non-small Cell Lung Cancer Using Plasma Specimen

Circulating tumor DNA (ctDNA), a tumor-derived fraction of cell-free DNA (cfDNA), has emerged as a promising marker in targeted therapy, immunotherapy, and minimal residual disease (MRD) monitoring in postsurgical patients. However, ctDNA level in early-stage cancers and postsurgical patients is ver...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jianping, Pu, Yue, Lin, Rui, Xiao, Shanshan, Fu, Yingxue, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928926/
https://www.ncbi.nlm.nih.gov/pubmed/35308511
http://dx.doi.org/10.3389/fmed.2022.822200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928926/
https://www.ncbi.nlm.nih.gov/pubmed/35308511
http://dx.doi.org/10.3389/fmed.2022.822200

Ejemplares similares